View Item 

Show simple item record

Diagnosed prevalence of Alzheimer’s disease and related dementias in Medicare Advantage plans
dc.contributor.authorJutkowitz, Eric
dc.contributor.authorBynum, Julie P.W.
dc.contributor.authorMitchell, Susan L.
dc.contributor.authorCocoros, Noelle M.
dc.contributor.authorShapira, Oren
dc.contributor.authorHaynes, Kevin
dc.contributor.authorNair, Vinit P.
dc.contributor.authorMcmahill‐walraven, Cheryl N.
dc.contributor.authorPlatt, Richard
dc.contributor.authorMcCarthy, Ellen P.
dc.date.accessioned2020-08-10T20:54:03Z
dc.date.availableWITHHELD_6_MONTHS
dc.date.available2020-08-10T20:54:03Z
dc.date.issued2020
dc.identifier.citationJutkowitz, Eric; Bynum, Julie P.W.; Mitchell, Susan L.; Cocoros, Noelle M.; Shapira, Oren; Haynes, Kevin; Nair, Vinit P.; Mcmahill‐walraven, Cheryl N. ; Platt, Richard; McCarthy, Ellen P. (2020). "Diagnosed prevalence of Alzheimer’s disease and related dementias in Medicare Advantage plans." Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 12(1): n/a-n/a.
dc.identifier.issn2352-8729
dc.identifier.issn2352-8729
dc.identifier.urihttps://hdl.handle.net/2027.42/156169
dc.description.abstractIntroductionOne- third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer’s disease (AD) and AD- related dementias (AD/ADRD).MethodsWe calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date.ResultsIn 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post- index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts.DiscussionThe prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee- for- service.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherMedicare
dc.subject.othermild cognitive impairment
dc.subject.otherdementia, Alzheimer’s disease
dc.subject.otherMedicare Advantage
dc.titleDiagnosed prevalence of Alzheimer’s disease and related dementias in Medicare Advantage plans
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurology and Neurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156169/2/dad212048.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156169/1/dad212048_am.pdfen_US
dc.identifier.doi10.1002/dad2.12048
dc.identifier.sourceAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
dc.identifier.citedreferenceLivingston S. Medicare Advantage industry sees slower growth for 2019. 2019 Jan 16 [cited 2019 Oct 30]. Available at: https://www.modernhealthcare.com/article/20190116/NEWS/190119927/medicare-advantage-industry-sees-slower-growth-for-2019
dc.identifier.citedreferenceAlzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018; 14 ( 3 ): 367 - 429.
dc.identifier.citedreferenceJutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017; 65 ( 10 ): 2169 - 2175.
dc.identifier.citedreferenceMitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med. 2009; 361 ( 16 ): 1529 - 1538.
dc.identifier.citedreferenceMitchell SL, Mor V, Gozalo PL, Servadio JL, Teno JM. Tube feeding in US nursing home residents with advanced dementia, 2000- 2014. JAMA. 2016; 316 ( 7 ): 769 - 770.
dc.identifier.citedreferenceBlumenthal D, Abrams MK. Tailoring complex care management for high- need, high- cost patients. JAMA. 2016; 316 ( 16 ): 1657 - 1658.
dc.identifier.citedreferenceTaylor DH Jr, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer’s disease. J Clin Epidemiol. 2002; 55 ( 9 ): 929 - 937.
dc.identifier.citedreferenceGoodman RA, Lochner KA, Thambisetty M, Wingo TS, Posner SF, Ling SM. Prevalence of dementia subtypes in United States Medicare fee- for- service beneficiaries, 2011- 2013. Alzheimers Dement. 2017; 13 ( 1 ): 28 - 37.
dc.identifier.citedreferencePlassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007; 29 ( 1- 2 ): 125 - 132.
dc.identifier.citedreferencePlassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008; 148 ( 6 ): 427 - 434.
dc.identifier.citedreferenceChen Y, Tysinger B, Crimmins E, Zissimopoulos JM. Analysis of dementia in the US population using Medicare claims: insights from linked survey and administrative claims data. Alzheimers Dement (N Y). 2019; 5: 197 - 207.
dc.identifier.citedreferenceCenters for Medicare & Medicaid Services. Chronic Conditions. 2019 [cited 2019 Nov 01]. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Chronic-Conditions/CC_Main.html
dc.identifier.citedreferenceBrown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R. Distributed health data networks: a practical and preferred approach to multi- institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010; 48 ( 6 Suppl ): S45 - S51.
dc.identifier.citedreferenceCenters for Medicare & Medicaid Services (CMS). Chronic Conditions Data Warehouse. 2019 [cited 2019 Oct 28]. Available at: https://www2.ccwdata.org/web/guest/condition-categories
dc.identifier.citedreferenceGagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64 ( 7 ): 749 - 759.
dc.identifier.citedreferenceLanga KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017; 177 ( 1 ): 51 - 58.
dc.identifier.citedreferenceMeyers DJ, Belanger E, Joyce N, McHugh J, Rahman M, Mor V. Analysis of drivers of disenrollment and plan switching among Medicare Advantage beneficiaries. JAMA Intern Med. 2019; 179 ( 4 ): 524 - 532.
dc.identifier.citedreferenceRahman M, Keohane L, Trivedi AN, Mor V. High- cost patients had substantial rates of leaving Medicare Advantage and joining traditional Medicare. Health Aff (Millwood). 2015; 34 ( 10 ): 1675 - 1681
dc.identifier.citedreferenceDuGoff E, Chao S. What’s driving high disenrollment in Medicare Advantage?. Inquiry. 2019; 56: 46958019841506.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
dad212048_am.pdf
Size:
365.8KB
Format:
PDF
View/Open
Name:
dad212048.pdf
Size:
182.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.